BOSTON, June 25, 2021 (GLOBE NEWSWIRE) – Block & Leviton LLP (www.blockleviton.com), a national securities firm, announces that it has filed a class action lawsuit against Athira Pharma, Inc. (NASDAQ: ATHA) on behalf of its shareholders. and some of their executives for securities fraud. Investors who purchased Athira shares between September 18, 2020 and June 17, 2021 and lost money are strongly advised to contact Block & Leviton attorneys at (617) 398-5600, email at contact firstname.lastname@example.org or visit our website for information on the case.
The deadline for the appointment as the lead plaintiff is August 24, 2021.
On June 17, 2021, after the markets closed, Athira announced that the company’s board of directors had temporarily suspended its President and CEO, Leen Kawas, pending investigation of “PhD theses promotions that Dr. Kawas performed while at Washington State University. “According to an investment analyst, the scientific basis for Athira came from the work Kawas and her colleagues developed in Washington State, and this news could” have a clear negative impact on how we / investors view the asset and / or management credibility “. Healthcare news outlets also raised concerns that images in Kawas academic articles may have been tampered with. In light of this news, Athira’s share price fell $ 7.09 per share, or nearly 39%, to close at $ 11.15 per share on June 18, 2021 due to unusually high trading volume.
The lawsuit was filed in the US District Court for the Western District of Washington and is entitled Wang v. Athira Pharma, Inc, No. 2: 21-cv-00861 (WD Wash.). The teaching time is from September 18th, 2020 to June 17th, 2021 inclusive. A class has not been certified and an attorney will not represent you until certification is made. If you do nothing, you can remain an absent class member.
If you purchased or acquired Athira shares between September 18, 2020 and June 17, 2021 and have any questions or relevant information about your statutory rights, please email (617) 398-5600 contact the lawyers at Block & Leviton @ blockleviton.com or visit our website. The deadline for the appointment as the lead plaintiff is August 24, 2021.
Block & Leviton LLP is a company dedicated to representing investors and maintaining the integrity of the country’s financial markets. The firm represents many of the largest institutional investors in the country as well as individual investors in securities disputes across the United States. The firm’s lawyers have collected billions of dollars for their clients.
This communication may constitute a solicitation.
BLOCK & LEVITON LLP
260 Franklin St., Suite 1860
Boston, MA 02110
Phone: (617) 398-5600
SOURCE: Block & Leviton LLP